Is there a role for measuring plasma aldosterone to guide the treatment of heart failure in specific populations?

Typically, there is no role in measuring aldosterone to guide therapy. In patients with HFpEF, the use of Aldactone is to help with membrane stabilization and management of RAAS inhibition. There are some reports of prior research supporting LV remodeling and reduction in myocardial fibrosis.

My answer would be yes. RAAS stimulation is a well-known mechanism in the pathophysiologic mechanisms that drive heart failure. This would be most relevant for HFrEF in black individuals as well as those with hypertension to exclude primary aldosteronism, since hypertension is a major risk factor fo...

The role of Aldosterone antagonists in preventing heart failure is debatable; however, in select populations with secondary hypertension due to hyperaldosteronism, testing and treating might be beneficial.